Yesterday was dominated by Biogen's news on their Alzheimer drug, but there was other news including Sarepta getting slapped with a clincial hold, Gilead CEO stepping down and, although not Life Science related, Facebook getting crushed after their earnings. Here is what I'm reading: Yesterday afternoon Eisai & Biogen Revealed Promising Alzheimer’s Data But Questions … Continue reading Thursday Morning Headlines
Tag: Antibiotics
Tuesday Reads
After a long weekend this is what I am reading to get the week started: Researchers have discovered potential new ways to treat a dangerous side effect of CAR T-cell therapy, which may mean the FDA can approve more centers to administer the therapy. A Tufts team has published research that explains how A. baumannii … Continue reading Tuesday Reads
What I’m Reading Today
Welcome to the work week. Here are some good reads to help you get started: CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it All of Us aims to compile health … Continue reading What I’m Reading Today
MattCorc 